NIGP 26912: Autonomic Drugs

NIGP 26912 Autonomic Drugs, an Item code, encompasses pharmaceutical products that act on the autonomic nervous system and related emergency medical supplies. State and local governments procure these products primarily to support community health and public safety initiatives, including opioid overdose response and substance abuse harm reduction. The sourcing bodies pursuing this code span county health departments and special-purpose health districts, which acquire naloxone, drug deactivation systems, and related pharmaceuticals in quantities ranging from hundreds to thousands of units annually to support emergency response, community health building operations, and public health programs. Vendors must meet standard compliance requirements including drug-free workplace certification, E-Verify enrollment, appropriate insurance coverage (workers' compensation, commercial general liability, professional liability), and legal authorization to work in the United States.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB required electronic bid submission through the county's e-Procurement Portal, with a response deadline of July 26, 2023, at 2:00 p.m. The contract offers a two-year initial term with an optional one-year renewal, awarded on a fixed-fee basis with all shipping and delivery costs included in vendor proposals. Potential FEMA funding introduces additional federal compliance requirements including adherence to the Clean Air Act and Federal Water Pollution Control Act. The procurement includes a three-month probationary period permitting Seminole County to terminate with or without cause, and vendors are subject to audit, record inspection, and potential termination for non-compliance.